2-Methyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine hydrochloride, 95%, 1g

SPhos, min. 98 %, 1 g, Glasverpackung

5-Chloro-1,3-dimethylpyrazole-4-carboxaldehyde, 95.0%, 1g

(2r,3r,5r,6r,7r,8r)-cubane-1-carboxylic acid, 95.0%, 250mg

(1-Hexylcyclopropyl)methanol, 100mg

3-(OXETAN-3-YL)PYRROLIDINE, 95.0%, 1g

3-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine, 95.0%, 250mg

5-(Thiophen-3-yl)pyridin-2-amine, 98%, 50mg

4-amino-N-(pyridin-2-yl)benzene-1-sulfonamide, 98.0%, 5g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 30 m, Ø-Innen 0,53 mm, Filmd. 1,00 µm, 1 Stück

Tridodecylamine, 95%, 250g

tert-Butyl 4-(5-iodopyrimidin-2-yl)piperazine-1-carboxylate, 98%, 1g

Z-Pry-OH, >99%, 25g